Forum Merger II Secures Sufficient Votes for Extension Following Delay
by Nicholas Alan Clayton on 2020-09-28 at 9:54am

Forum Merger II Corporation (FMCI)

Forum Merger II Corporation (FMCI) announced over the weekend that stockholders owning more than 65% of outstanding shares had submitted proxies voting to extend the company’s transaction deadline from September 30 to October 30.

Forum II faced an unprecedented situation last week as it announced it had convened and then adjourned its Thursday shareholder meeting without having received sufficient votes to pass the extension. With 61% of outstanding shares having voted, the extension received 99% approval, but this was nonetheless below the mandatory 65% threshold.

The company will proceed with its rescheduled special meeting for 9:00 a.m. September 30, 2020 when the votes will be officially recorded. Shareholders may still vote until 11:59 pm ET Tuesday, September 29.

So… What happened? One plausible theory is issues with the retail crowd. Currently, FMCI’s shareholder base is comprised of ~23% institutional investors, so the vast majority of its shareholders are retail.  Retail continues to grow to a larger share of the SPAC investor base, especially so when the target is consumer facing and well known like Itella International, or the “Tatooed Chef”.

Many of these investors might be unfamiliar with the proxy process and might have misunderstood how and when to cast a vote. Another theory is that there were technical issues with the voting process. A quick review of Twitter shows a number of people stating they experienced multi-hour wait times on the phone, possibly preventing many from casting their vote

Regardless, this is a new risk that teams now need to consider.  The good news for FMCI is, they had some cushion as far as time before they run out their clock and therefore were able to adjourn to the 30th.  In a nightmare scenario, they could have scheduled this vote on their deadline day and then not had enough voters, which would have resulted in a liquidation.

SPAC Insider analyst Eric Weidemann contributed to this report.

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved